NVS-STG2: Serum cytokine profile and clinicopathological findings in oral lichen planus, oral lichenoid lesions and stomatitis
BAY-1895344 : “Damage Incorporated: Discovery of the Potent, Highly Selective, Orally Available ATR Inhibitor BAY 1895344 with Favorable Pharmacokinetic Properties and Promising Efficacy in Monotherapy and in Combination Treatments in Preclinical Tumor Models”